Phase I Oncology Drug Development


Phase I Oncology Drug Development
Du sparer Spar kr. 55,00 med Saxo Premium
  • Leveringstid 5-7 hverdage
  • Forventet levering 15-03-2021
Hvis du køber til medlemspris, bliver du automatisk medlem af Saxo Premium. De første 30 dage er gratis, derefter koster det 99,-/md. Medlemskabet fornyes automatisk og kan altid opsiges. Læs mere om alle fordelene her.
Format:
Bog, hardback
Udgivelsesdato:
01-09-2020
Sprog:
Engelsk
Udgave:
1st ed. 2020.
  • Beskrivelse
  • Yderligere info
  • Anmeldelser

This book provides a detailed review of how oncology drug development has changed over the past decade, and serves as a comprehensive guide for the practicalities in setting up phase I trials. The book covers strategies to accelerate the development of novel antitumor compounds from the laboratory to clinical trials and beyond through the use of innovative mechanism-of-action pharmacodynamic biomarkers and pharmacokinetic studies.The reader will learn about all aspects of modern phase I trial designs, including the incorporation of precision medicine strategies, and approaches for rational patient allocation to novel anticancer therapies. Circulating biomarkers to assess mechanisms of response and resistance are changing the way we are assessing patient selection and are also covered in this book. The development of the different classes of antitumor agents are discussed, including chemotherapy, molecularly targeted agents, immunotherapies and also radiotherapy. The authors also discuss the lessons that the oncology field has learnt from the development of hematology-oncology drugs and how such strategies can be carried over into therapies for solid tumors. There is a dedicated chapter that covers the specialized statistical approaches necessary for phase I trial designs, including novel Bayesian strategies for dose escalation.This volume is designed to help clinicians better understand phase I clinical trials, but would also be of use to translational researchers (MDs and PhDs), and drug developers from academia and industry interested in cancer drug development. It could also be of use to phase I trial study coordinators, oncology nurses and advanced practice providers. Other health professionals interested in the treatment of cancer will also find this book of great value.

Vis mereVis mindre

Udgivelsesdato:
01-09-2020
ISBN13:
9783030476816
Vægt:
703 g
Dybde:
21 mm
Bredde:
155 mm
Højde:
235 mm
Format:
Hardback
Forfattere

    Vis mereVis mindre

    Vis mereVis mindre

    Fandt du ikke hvad du søgte?

    Hvis denne bog ikke er noget for dig, kan du benytte kategorierne nedenfor til at finde andre titler. Klik på en kategori for at se lignende bøger.

    Velkommen til Saxo - din danske boghandel!

    Hos os kan du handle som Gæst, Saxo-bruger eller Saxo Premium-medlem. Du bestemmer selv, og vores kundeservice sidder altid klar med hjælp.

    Om medlemspriser hos Saxo

    Hvis du køber til medlemspris, bliver du automatisk medlem og får del i de mange fede fordele. De første 30 dage er gratis for nye brugere, og derefter koster det kun 99,-/md. Medlemskabet fornyes automatisk, og du kan altid opsige det. Læs mere om fordelene ved Saxo Premium her.

    Machine Name: SAXO082